Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NDAQ vs GSK✓SelectedUSD · GSKNDAQ vs GSK performance historyLatest closeAs of-3.12%11/17
Stock and ETF performance explorer

NDAQ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+60.9%
GSK return
+43.9%
Excess return
+17.0%
Maximum drawdown
-32.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.1%-2.3%-0.8%-2.7%
7D-4.4%-3.0%-1.4%-3.9%
30D+11.9%+0.4%+11.5%+11.8%
3M+9.1%-1.2%+10.3%+9.2%
6M+16.3%+0.9%+15.3%+15.9%
YTD+9.3%+4.0%+5.3%+7.7%
1Y+24.3%+7.3%+17.0%+21.7%
3Y+104.7%+57.1%+47.6%+80.5%
5Y+60.9%+43.0%+18.0%+35.3%
All+60.9%+43.9%+17.0%+35.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling